Aeron Tynes Hammack, a physicist by training and currently interim facility director of the Nanofabrication Facility at the ...
A new artificial intelligence-powered cancer detection tool is under review by the Food and Drug Administration and could ...
A new tool that identifies early cancer risk in patients is currently under review with the Food and Drug Administration (FDA ...